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Abstract 
Objectives: To asses if administrating mothers giving birth by cesarean delivery 
prophylactic antibiotics either before skin incision or immediately after cutting the 
umbilical cord influences gut microbiota colonization and antibiotic susceptibility of 
the gut bacteria in the newborn.  Antibiotics administered before skin incision lowers 
the risk of surgical site infections for the mothers, but also exposes the fetus to the 
antibiotic.  
 
Methods: Forty-two pregnant women scheduled for elective cesarean section were 
recruited at Odense University Hospital, Denmark, and randomly assigned to receive 
cefuroxime either before skin incision or immediately after the umbilical cord was 
cut. Fecal samples were collected from all infants at age 10 days and 9 months. 
Composition of the gut microbiota was determined by 16S rRNA gene amplicon 
high-throughput sequencing. Gram-positive cocci and Enterobacteriaceae were 
isolated and identified before antimicrobial susceptibility tests were performed by 
disk diffusion.  
 
Results: No clear difference in the composition of the gut microbiota was observed 
between infants whose mothers received cefuroxime before or after cesarean delivery 
at neither time point, though surprisingly at 9 months of age, but not at 10 days of 
age, the number of observed species was higher in infants where mothers received 
cefuroxime after cord clamping. No differences in antimicrobial susceptibility of 
Enterobacteriaceae, Enterococcus spp., and Staphylococcus spp. were seen at 10 days.  
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Conclusion: Timing of cefuroxime administration to mothers undergoing cesarean 
section does not have major effects on gut microbiota and bacterial antibiotic 
resistance traits in infants. 
 
Clinical trials registration: “Antibiotics and Microbiota among newborn Infants”, 
NCT02072798. 
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Introduction 
Birth by caesarean delivery is common, with cesarean delivery rates exceeding 50% 
in some countries.1 In Denmark approximately 20% of all newborns are born by 
cesarean delivery.2 Women undergoing cesarean delivery compared with vaginal 
delivery demonstrate an increased risk of postpartum infections with endometritis, 
urinary tract infection, and wound infection being the most common.3 Prophylactic 
administration of antibiotics to the mother lowers the risk of surgical site infection. It 
is thus standard cesarean delivery procedure to administer to the mother a single 
prophylactic dose of cefuroxime (1500 mg) or other broad spectrum antibiotics either 
shortly before skin incision or immediately after umbilical cord clamping.4 While 
several studies have shown that administering the antibiotics to the mother 30-60 
minutes before skin incision is optimal for lowering SSI risk,5-9 this also exposes the 
fetus to the antibiotic via placental transfer.10 To avoid unintended fetal exposure to 
antibiotics during CS, antibiotics at many hospitals are administered to the mother 
immediately after the cord is clamped.11  
 
At birth, the neonate’s gastrointestinal tract is rapidly colonized by  microorganisms.12 
Initially the microbial community composition is relatively simple.13 During the first 
year of life the gut microbiota, influenced by environmental factors (breast vs. 
formula feeding; introduction of weaning food, exposure to antibiotics etc.), gradually 
develops into a more adult-like, complex microbiota.14-17 Early life gut colonization 
plays pivotal roles in development of intestinal functions and postnatal immune 
maturation, which might influence long-term health and risk of development of 
disorders, e.g. autoimmune diseases.18-21  
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High exposure to antibiotics during early life has been shown to influence long-term 
structure of the gut microbiota and might be a risk factor for the development of 
certain diseases, such as asthma and obesity.21-26 Furthermore, since early life 
antibiotic exposure increases the occurrence of antibiotic resistant gut bacteria, 
especially Enterobacteriaceae, which can have serious health implications27 it is 
highly recommended to limit exposure to antibiotics in infants as much as possible. 
However, short and long-term effect on the developing gut microbiome of very early 
and brief (i.e. at or around birth) exposure to antibiotics is unclear.  
 
Cefuroxime administered intravenously to the mother shortly before cesarean delivery 
is cleared from infants’ blood plasma approximately three times more slowly than in 
adults, but nevertheless a single maternal dose of 1500 mg cefuroxime is cleared from 
the infant within 24 hours.10 In the present study we aim to investigate whether 
maternal exposure to antibiotics shortly before or immediately after parturition 
influences the gut microbiota of the infant short- and moderately long-term, and 
whether use of antibiotics in this window of time increases the prevalence of 
antibiotic resistant gut bacteria.  
 
Methods 
Study Subjects 
This study was performed at the Department of Gynaecology and Obstetrics, Odense 
University Hospital, Denmark from February 2014 to July 2014 and is registered in 
Clinical Trials as “Antibiotics and Microbiota among newborn Infants”, 
NCT02072798. Inclusion criteria were planned cesarean delivery, age above 18 years, 
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a pre-gestational body mass index (BMI) less than 30. Forty-two women were 
randomly assigned to receive a single dose of intravenous cefuroxime (1500 mg), 
either administered 15 to 60 minutes prior to surgical incision (Pre, n = 22) or 
immediately after umbilical cord clamping (Post, n = 20). Details on caesarean 
delivery procedure, recruitment procedure and medical ethics have been reported 
elsewhere.10 A restricted block randomization sequence was created with a 1:1 
allocation using a fixed block size of 4. The block size was unknown to the 
investigators, study nurse and participants during the trial. No stratification was used. 
A data manager with no clinical involvement in the trial prepared the randomization 
sequence using computer-generated random numbers. Infants whose mother received 
cefuroxime before skin excision (Pre) had blood sampled to determine cefuroxime 
clearance from the blood.10 It was deemed unethical to also sample blood from infants 
not exposed to the antibiotic (Post) and the study consequently not blinded. Study 
infants were healthy, did not receive any antibiotics postnatally, and were discharged 
between two to five days after birth. Infant health conditions after hospital discharge 
were monitored by a trained nurse and early feeding practices (exclusive breast 
feeding, mix breast feeding and infant formula or exclusive infant formula) were 
recorded. 
 
During the first 10 days of life 15 infants were exclusively breast fed, 4 were 
exclusively fed formula milk and 25 infants had received both formula and breast 
feeding. No diet information was recorded at age of 9 months. Fecal samples were 
collected from the infants during the nurse/midwife´s visit 10 days after birth and 9 
months after birth. Fecal samples were obtained from 44 infants at day 10 and from 
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42 infants at 9 months (one set of twins withdrew from the study). The fecal samples 
were transferred into sterile tubes and stored at - 60°C or colder until further analyses. 
 
Ethics  
The trial was approved by the Danish Health and Medicines Authority (EudraCT 
2012-002068-29), the Committee on Biomedical Research Ethics (S-20130117), 
Danish Data Protection Agency (2008-58-0035) and was monitored by the local Good 
Clinical Research Unit (NCT02072798). All mothers gave written consent prior to 
cesarean delivery and prior to collecting any samples.  
DNA extraction  
Approximately 200 mg of fecal sample was weighted into a PowerSoil Bead Tube 
and total DNA extracted using the MoBio PowerSoil DNA isolation kit (MOBIO 
Laboratories, Carlsbad, CA, USA), following manufacturer’s instructions, except that 
an initial bead beating step was included to increase cell lysis.  Prior to DNA 
extraction, samples were placed into the PowerBead tubes and heat treated at 65°C for 
10 min and then at 95°C for 10 min. Subsequently, solution C1 was added and bead-
beating performed in a FastPrep (MP Biomedicals, Santa Ana, CA, USA) using 3 
cycles of 15 s each, at a speed of 6.5 m s-1. The DNA concentration was measured 
using Nanodrop (ND-100, NanoDrop Technologies, USA). Extracted DNA was 
stored at -60oC until further analysis.  
 
16S rRNA gene amplicon sequencing 
The fecal composition of the bacterial microbiota was determined using tag-encoded 
16S rRNA gene MiSeq-based (Illumina, CA, USA) high throughput sequencing. The 
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V3-V4 region of the 16S rRNA gene was amplified using primers compatible with the 
Nextera Index Kit (Illumina, CA, USA; adapters in bold): NXt_341_F: 5’-
TCGTCGGCA GCGTCAGATG TGTATAAGAG ACAGCCTAYG 
GGRBGCASCAG-3’ and NXt_806_R: 5’-GTCTCGTGGG CTCGGAGATG 
TGTAAAGAGA CAGGGACTAC NNGGGTATC TAAT-3’; Library construction 
and sequencing was carried out as previously described.28  
Amplicon sequencing data analysis 
The raw dataset containing pair-ended reads was merged, trimmed, filtered from 
chimeric reads with the USEARCH pipeline,29 and subjected to zero radius 
Operational Taxonomic Units (zOTU) construction using UNOISE.30 Taxonomy 
classification was conducted using the SINTAX algorithm31 based on the Ribosomal 
Database Project (RDP, release 11, update 5, 2016).32 The Quantitative Insight Into 
Microbial Ecology (QIIME) open source software package (version 1.8.0) was used 
for subsequent analysis steps. 32,33  
 
Weighted, unweighted and generalized UniFrac distance metrics were calculated 
based on subsampled OTU-tables (14,000 reads per sample) and projected with 
Principal Coordinate Analysis (PCoA) plots. Permutational Multivariate Analysis of 
Variance (PERMANOVA) (‘Adonis’ R package) was used to evaluate group 
differences based on weighted, unweighted and generalized UniFrac distance 
matrices. The differences in taxa abundance and prevalence between categories were 
estimated with a statistic framework: analysis of composition (ANCOM) of microbes 
based on non-normalized OTU-table summarized to the species level (all p-values 
False Discovery Rate (FDR) corrected).33  
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Alpha diversity expressed as observed species and Shannon indexes were computed 
for rarefied OTU tables (14,000 reads per sample) using the alpha rarefaction 
workflow. Alpha diversity differences were tested by t-test using the non-parametric 
(Monte Carlo) method (999 permutations) that is implemented in the compare alpha 
diversity workflow.  
 
The full amplicon sequencing data set including metadata has been uploaded to the 
European Nucleotide Archive (ENA) under the accession number PRJEB25411.  
 
Bacterial isolation and identification 
The isolation and identification of bacteria from the fecal samples was carried out as 
described previously.13 Briefly, fecal samples from day 10 (~200mg) were emulsified 
and transferred in sterile saline (1 mL) and mixed thoroughly before being inoculation 
onto nonselective and selective agar (SSI Diagnostica, Copenhagen, Denmark). 
Samples were streaked onto Blood agar plates (5% horse blood), blue agar plates 
(modified Drigalski) and chocolate agar plates and incubated aerobically at 37oC for 
24 hours (48 hours for chocolate agar plates). Colonies were selected based on 
morphology and sub-cultured to get pure isolates. Bacterial isolates were then 
identified by matrix-assisted laser desorption ionization-time of flight (MALDI-
TOF).34 Identified isolates were stored in Luria-Bertani (LB) broth containing 20% 
glycerol at -80oC.  
Antimicrobial Susceptibility testing 
The antibiotic susceptibility of  the fecal bacterial isolates was determined by Kirby-
Bauer disk diffusion method according to Clinical Laboratory Standards Institute 
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recommendation35 using disks containing ampicillin (10 µg), ciprofloxacin (5 µg), 
cefuroxime (30 µg), gentamicin (10 µg) or piperacillin/tazobactam (100 µg/10 µg). 
The inhibition zone diameter was measured after anaerobic incubation at 37oC within 
18 to 24 hours and results were categorized as resistant (R), intermediate (I) or 
susceptible (S) also according to Clinical Laboratory Standards Institute.35  
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Results  
Composition of the gut microbiota  
A total of 86 fecal samples were obtained from 44 babies who donated fecal samples 
at 10 days (Pre, n=24; Post n=20) and 9 months of age (Pre, n=22; Post, n=20) with 
two twin set of babies participating at 10 days and only one set of twin babies at 9 
months (Figure 1).  
 
High throughput 16S rRNA gene amplicon sequencing was used to determine 
composition of the gut microbiota. No differences in alpha-diversity measures 
between the groups were observed at day 10 as determined by Observed Species (Pre 
= 148±49, Post = 151±59, p=0.76; Figure 2, Online) and Shannon Diversity indices 
(Pre: 3.7±1, Post: 4.0±1, p=0.60; not shown). At 9 months of age, the number of 
Observed Species was elevated in the Post group (Pre = 361±141, Post = 496±151, 
p=0.012; Figure 2, Online) while the Shannon Diversity Index did not differ 
significantly between the groups (Pre = 5.2±1.1, Post = 6.0±1.3, p=0.062).  
 
Unweighted, weighted and generalized UniFrac distance metrics showed that very 
early life antibiotic exposure via the umbilical cord does not influence gut microbiota 
composition neither short (10 days) nor longer (9 months) term (Figure 3). When 
analyzing across the entire cohort diet had no significant effect on gut microbiota 
composition after 10 days (Figure 4, Online). It should be noted that only 4 of the 44 
investigated infants were exclusively formula fed with another 25 infants being both 
formula and breast fed, and 15 infants being exclusively breastfed at day 10. 
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At the compositional level no taxa were found to differ significantly between Pre and 
Post groups either at 10 days or 9 months of age (ANCOM, q>0.05 in all cases). At 
day 10 the gut microbiota composition of both groups were dominated by OTUs 
belonging to family Enterobacteriaceae and Veillonella dispar, while also 
Bifidobacterium spp. and Clostridium spp. were present in noticeable numbers 
(Figure 5). At 9 months, the gut microbiota of the infants was dominated by obligate 
anaerobes, mainly Faecalibacterium prausnitzii, Blautia and other Clostridales, 
Lachnospiraceae, Bifidobacterium breve, Bacteriodes and Akkermansia muciniphila 
(Figure 5). 
 
A total of 153 facultative anaerobic and aerobic bacteria were isolated from fecal 
samples collected at 10 days of age. Most isolates were Enterococcus spp., (mainly 
Enterococcus faecalis), Staphylococcus spp. (Staphylococcus epidermidis and S. 
aureus) and Enterobacteriaceae (mainly Enterobacter cloacae and Klebsiella 
pneumoniae) (Table 1, Online). The antibiotic susceptibility of the gram-positive 
isolates was tested against ciprofloxacin, ampicillin and gentamicin (Table 2, Online). 
No clear differences in antibiotic susceptibility was observed between isolates 
obtained from Pre and Post group infants, with only 1 (Pre) and 2 (Post) gram-
positive isolates being resistant to any one of three tested antibiotics. Gram-negative 
isolates were tested against cefuroxime, ciprofloxacin, ampicillin, gentamicin and 
pipercillin-tazobactam. Only resistance against ampicillin was widespread among 
gram-negative isolates from both the Pre and Post group isolates (Table 3) with no 
differences observed between groups. 
 
Discussion 
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When undergoing cesarean section, the mother is administered prophylactic 
antibiotics to prevent post-surgery complications such as surgical site infection, 
endometritis and urinary tract infection.3 According to the 2012 Danish National 
Obstetric Guideline on antibiotics and C-sections4 women giving birth by C-section 
are given a single prophylactic intravenous dose (1500 mg) of cefuroxime 15-60 
minutes before skin incision. However, hospital practices still differ. At the time of 
this intervention, the usual practice at Odense University Hospital was to administer a 
single-dose of cefuroxime immediately after umbilical cord clamping to avoid 
placental transfer of the antibiotic to the fetus.10 Several studies found that 
administration of prophylactic antibiotics pre-incision reduce maternal wound 
infections.7-9 Lowering the risk wound infection of the mother is important not only 
for the mother, but also for the new-born – and from a societal perspective it may also 
help in reducing the cost of extended stays in the hospital.  
 
We have previously showed that  cefuroxime does pass the placental barrier, and that 
a dose of 1500 mg administered to the mother before skin incision is cleared from the 
blood of the new-born within 24 h10, but whether this very early exposure to 
antibiotics nevertheless influences GM composition and antibiotic susceptibility of 
the gut bacteria in the new-born has previously not been investigated. To assess the 
effect of maternal antibiotic exposure on the infant we investigated gut microbiota 
composition 10 days and 9 months after birth. Ten days was chosen, as an early time 
point, where the GM had started to settle after the very dynamic phase immediately 
birth, when the gut is first colonized. Nine months was chosen as a more long-term 
time point representing the period after introduction of weaning food and the gradual 
transition towards a more adult-like gut microbiota.16 
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At day 10 the gut microbiota composition of both groups were dominated by to the 
family Enterobacteriaceae and genus Veillonella, while Bifidobacterium spp. and 
Clostridium spp. were present in noticeable numbers, too (Figure 5). The dominance 
of Enterobacteriaceae early in life is in agreement with previous findings,16 although 
the relative abundance of especially Bifidobacterium spp. and Bacteroides tends to be 
higher in infants born vaginally16 compared with the infants born by cesarean delivery 
in the present study. At 9 months, the gut microbiota of the infants was dominated by 
obligate anaerobes, mainly Faecalibacterium and Blautia and other Clostridales, 
Lachnospiraceae, Bifidobacterium, Bacteriodes and Akkermansia which is also in 
agreement with previous investigations of infant gut microbiota around one year of 
age (Figure 5).16  
 
In terms of Observed Species and Shannon Diversity index, we did not observe any 
differences between Pre and Post parturition antibiotic administration at 10 days of 
age, but at 9 months of age we observed a higher number of Observed Species in the 
Post group (Fig. 1, Online). Neither unweighted, weighted nor generalized Unifrac 
distance metrics indicated GM compositional differences between Pre and Post 
groups at 10 days and 9 months of age (Fig. 2). It is important to note that in the 
present study we investigated only the effect of very early-life exposure to cefuroxime 
on gut microbiota composition. Maternal exposure to cefuroxime around the time of 
birth could also influence the maternal milk microbiome.   
 
The elevated number of observed species in the Post group at 9 months of age could 
indicate an altered succession of bacteria among infants exposed to the antibiotic, but 
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this effect would be expected to be more pronounced at 10 days of age. As no other 
indices indicate an effect of very early-life exposure to cefuroxime on the gut 
microbiota it seems more likely that the observed difference in observed species 
between Pre and Post groups at 9 months of age is a result of the substantial 
reorganization that infant gut microbiota undergoes in the period after weaning16, 36, 
but potential long-term effects of very early-life exposure to antibiotics cannot be 
completely excluded.  
 
Early life antibiotic exposure has previously been reported to increase the frequency 
of antibiotic resistant bacterial gut microbiota members, especially 
Enterobacteriaceae.27 However, in the present study we observed no differences in 
antibiotic susceptibility profiles of gram-positive cocci and Enterobacteriaceae 
isolated from Pre and Post fecal samples (10 days). The observation that a relatively 
high fraction of the investigated Klebsiella pneumoniae and Enterobacter cloacae 
isolates were resistant to ampicillin is not surprising, as ampicillin has been widely 
used to treat bacterial infections for decades.  
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Figure Legends 
 
Figure 1. Study design.  
 
Figure 2 (Online). Rarefaction curves based on Observed Species index (16S rRNA gene amplicon 
sequencing based). Significant (p<0.05) differences indicated by *. 
 
Figure 3. Gut microbiota compositional similarities between the Pre and Post groups depicted as 
Principle Coordinate Analysis (PCoA) plots based on unweighted (u), weighted (w) and generalized 
(g) UniFrac distance metrics showing no clear differences between the gut microbiota of infants 
born by caesarean section whose mothers received cefuroxime before (red, Pre) or after (blue, Post) 
skin incision at 10 days and 9 months of age. PERMANOVA values shown each figure. Gut 
microbiota composition determined by 16S rRNA gene amplicon sequencing.  
 
Figure 4 (Online). The influence of diet (BF, exclusive breast feeding; MME, formula feeding, 
Both, mixed breast and formula feeding) on gut microbial compositional similarities depicted as 
PCoA plots based on unweighted (u), weighted (w) and generalized (g) UniFrac distance metrics at 
10 days.  PERMANOVA results are given in each figure. GM composition determined by 16S 
rRNA gene amplicon sequencing. 
 
Figure 5. The relative distribution of the most abundant taxa 
Relative distribution of the top 20 most abundant taxa at (A) 10 days and (B) 9 months of age 
determined using 16S rRNA gene amplicon sequencing.  
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Table 1 (Online). Distribution of bacterial isolated from fecal samples from 10 days old infants born 
by caesarean delivery for which mother was administered a single dose of cefuroxime either before 
(Pre) or after (Post) umbilical cord clamping. Isolates were identified by MALDI-TOF. 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*     Enterococcus avium, Enterococcus maldoratus, Enterococcus faecium  
**   Staphylococcus hominis, Staphylococcus lugdunensis 
***  Aerococcus viridans, Micrococcus lutues  
†    Enterobacter aerogenes, Enterobacter asburie, Klebsiella oxytoca,  
      Citrobacter braakii, Citrobacter fruendii, Escherichia coli,  
      Leclercia adecarboxylata 
§   Acinetobacter junii, Stenotrophomonas maltophilia  
 
  Number tested (%) 
Bacterial isolate Pre Post 
Gram positive bacteria  N = 54 N = 31 
Enterococcus spp. 27 16 
Enterococcus faecalis 20 (21.3) 16 (32.7) 
Other Enterococcus spp.* 7 (7.4) 0 (0.0) 
Staphylococcus spp. 27 13 
Staphylococcus epidermidis  16 (17.0) 8 (16.3) 
Staphylococcus aureus 9 (9.6) 2 (4.1) 
           Other Staphylococcus spp.** 2 (2.1) 3 (6.1) 
Other gram-positive bacteria*** 0 (0.0) 2 (4.1) 
Gram negative bacteria N = 40 N = 18 
Enterobacteriaceae 39 17 
Klebsiella pneumoniae 9 (9.6) 6 (12.2) 
Enterobacter cloacae 16 (17.0) 8 (16.3) 
           Other Enterobacteriaceae† 14 (14.9) 3 (6.1) 
Other gram-negative bacteria §  1 (1.1) 1 (2.0) 
Total N=153 94 (100) 49 (100) 
 
 
 
 
 
              
 
 
 
 
 
 
 
 
 
Table 2 (online): Antibiotic susceptibility of Gram-positive bacteria isolated from feces 10 days after birth from babies born by cesarean delivery for 
which the mother was administered a single dose of cefuroxime either before (Pre) or after (Post) umbilical cord clamping. R, Resistant, I, 
Intermediate, S, Susceptible, as determined by the Kirkby-Bauer test. NA, not applicable. 
  Pre  Post 
 Antibiotic R  I S  R I S 
Enterococcus faecalis  
(Pre, n=20; Post, n=16) 
Ciprofloxacin 0/20 (0.0) 10/20  (50.0) 10/20  (50.0)  0/16   (0.0) 10/16   (62.5) 6/16   (37.5) 
Ampicillin 0/20 (0.0) 0/20  (0.0) 20/20  (100.0)  0/16   (0.0) 0/16   (0.0) 16/16   (100.0) 
Other Enterococcus spp. 
(Pre, n=7; Post, n=0) 
Ciprofloxacin 0/7 (0.0) 2/7 (28.6) 5/7 (71.4)  NA NA NA 
Ampicillin 0/7 (0.0) 0/7 (0.0) 7/7 (100.0)  NA NA NA 
Staphylococcus 
epidermidis  
(Pre, n=16; Post, n=8) 
Ciprofloxacin 0/16 (0.0) 0/16  (0.0) 16/16  (100.0)  1/8 (12.5) 0/8 (0.0) 7/8 (87.5) 
Gentamicin 0/16  (0.0) 0/16  (0.0) 16/16  (100.0)  0/8 (0.0) 0/8 (0.0) 8/8 (100.0) 
Staphylococcus aureus  
(Pre, n=9;Post, n=2) 
Ciprofloxacin 0/9 (0.0) 2/9 (22.2) 7/9 (77.8)  0/2 (0.0) 0/2  (0.0) 2/2  (100.0) 
Gentamicin 1/9 (11.1) 0/9 (0.0) 8/9 (88.9)  0/2  (0.0) 1/2  (50.0) 1/2  (50.0) 
Other Staphylococcus spp. 
(Pre, n=2; Post, n=3) 
Ciprofloxacin 0/2 (0.0) 0/2 (0.0) 2/2 (100.0)  0/3 (0.0) 1/3 (33.3) 2/3 (66.7) 
Gentamicin 0/2 (0.0) 1/2 (50.0) 1/2 (50.0)  1/3 (33.3) 0/3 (0.0) 2/3 (66.7) 
 
 
 
Table 3: Antibiotic susceptibility of gram-negative (Enterobacteriaceae) bacteria isolated from feces 10 days after birth from babies born 
by cesarean delivery for which the mother was administered a single dose of cefuroxime either before (Pre) or after (Post) umbilical cord 
clamping. R, Resistant, I, Intermediate, S, Susceptible, as determined by the Kirkby-Bauer test. NA, not applicable. 
  Pre  Post 
 Antibiotic R I S  R I S 
Klebsiella pneumoniae 
(Pre, n= 9; Post, n=6) 
Cefuroxime 0/9 (0.0) 1/9 (11.1) 8/9 (88.9)  0/6 (0.0) 0/6 (0.0) 6/6 (100.0) 
Ciprofloxacin 0/9 (0.0) 1/9 (11.1) 8/9 (88.9)  0/6 (0.0) 0/6 (0.0) 6/6 (100.0) 
Ampicillin 5/9 (55.6) 3/9 (33.3) 1/9 (11.1)  3/6 (50.0) 3/6(50.0) 0/6 (0.0) 
Gentamicin 0/9 (0.0) 0/9 (0.0) 9/9 (100.0)  0/6 (0.0) 0/6 (0.0) 6 /6(100.0) 
Pipercillin-
tazobactam 0/9 (0.0) 1/9 (11.1) 8/9 (88.9) 
 0/6 (0.0) 0/6 (0.0) 6/6 (100.0) 
Enterobacter cloacea       
(Pre, n=16; Post, n=8) 
Cefuroxime 1/16 (6.3) 13/16 (81.3) 2/16 (12.5)  2/8 (25.0) 2/8 (25.0) 4/8 (50.0) 
Ciprofloxacin 0/16 (0.0) 0/16 (0.0) 16/16 (100.0)  0/8 (0.0) 0/8 (0.0) 8/8 (100.0) 
Ampicillin 7/16 (43.8) 4/16 (25.0) 5/16 (31.3)  5/8 (62.5) 2/8(25.0) 1/8 (12.5) 
Gentamicin 0/16 (0.0) 0/16 (0.0) 16/16 (100.0)  1/8 (12.5) 0/8 (0.0) 7/8 (87.5) 
Pipercillin-
tazobactam 1/16 (6.3) 2/16 (12.5) 13/16 (81.3) 
 0 /8(0.0) 3/8 (37.5) 5/8 (62.5) 
Other Enterobacteriaceae  
(Pre, n=14; Post, n=3) 
Cefuroxime 0/14 (0.0) 0/14 (0.0) 14/14 (100.0)  0/3 (0.0) 0/3 (0.0) 3/3 (100.0) 
Ciprofloxacin 0/14 (0.0) 0/14 (0.0) 14/14 (100.0)  0/3 (0.0) 0/3 (0.0) 3/3 (100.0) 
Ampicillin 1/14 (7.1) 1/14 (7.1) 12/14 (85.7)  1/3 (33.3) 1/3 (33.3) 1/3 (33.3) 
Gentamicin 0/14 (0.0) 0/14 (0.0) 14/14 (100.0)  0/3 (0.0) 0/3 (0.0) 3/3 (100.0) 
Pipercillin- 
tazobactam 0/14 (0.0) 0/14 (0.0) 14/14 (100.0) 
 0/3 (0.0) 0/3 (0.0) 3/3 (100.0) 
